Hypertensive intracranial hemorrhage

Findings

Axial CT of the head shows a large hyper dense focus with peripheral hypo density in the left frontal lobe, causing sulcal effacement at the frontal cortex but no significant midline shift. Surrounding rim of low density represents edema (image 1). Unenhanced MRI of the brain shows an the same mass-like focus in the left frontal lobe, which has an isointense center with a hyper intense rim (image 2). Post gadolinium-enhanced T1 image of the brain shows no internal enhancement of this lesion (image 3).


Differential diagnosis:
- Hypertensive intracranial hemorrhage
- Ruptured arteriovenous malformation (AVM)
- Hemorrhagic intracranial mass
- Posttraumatic cerebral contusion


Diagnosis: Hypertensive intracranial hemorrhage


Acute blood appears hyper dense of unenhanced head CT.
Without a history of trauma, intraparenchymal brain hemorrhage on head CT could represent a hemorrhagic mass, a ruptured AVM, or a hemorrhagic brain tumor (primary or metastatic).
MRI with and without contrast is the best diagnostic tool for determining if a mass lesion is present, and for evaluating the age of the intracranial hemorrhage.
Acute blood products on T1 appear hypo intense to isointense (image 2), whereas subacute and chronic hematoma are hyper intense.
Neoplasms should enhance on post contrast T1. The lack of enhancement in this patient on post contrast T1 excludes neoplasm (image 3).

Sequestered disk

Findings

There is an non- enhancing ovoid mass slightly hyper intense to muscle on both T1 and T2 sequences, in the anterior epidural space at the L3 level, measuring approximatelyl 12 x 8 x 12 mm. This is not contiguous with any adjacent disks. No signal dropout on fat-saturated sequences. The mass causes severe stenosis of the left half of the spinal canal at the L3 level, compressing the left descending nerve roots. T1 and T2 hyper intensity at the endplates abutting L2-L3 disc space representing Modic Type II changes. There is intervertebral disk space height loss at L2-L3 with severe disk desiccation changes.


Differential diagnosis:
- Sequestered disk
- Extruded disk
- Failed back surgery
- Epidermoid
- Epidural abscess
- Epidural hematoma
- Lipoma


Diagnosis: Sequestered disk


A focal disk protrusion is an extension of intervertebral disc material (nucleus pulposus) beyond the vertebral margin (AP diameter < mediolateral diameter). An extruded disk is one in which the nucleus pulposus has herniated through a rent in the annulus fibrosis. The AP diameter > ML diameter, and the disk may migrate craniocaudally, but maintains attachment to the parent disk (frequently symptomatic).
When extruded disk material loses its attachment to the parent disk, it is referred to as a sequestered disk. Sequestered discs usually lodge in the anterior epidural space (AES), just anterior to the posterior longitudinal ligament, and migrate either cephalad or caudad (with equal frequency). Because there is a midline septum associated with the PLL in the AES, the fragment is usually just off midline (to the right or left). Rarely, the sequestered fragment may migrate beyond the PLL into the posterior epidural space, through the dural ( intrathecal location), or into the paraspinal muscles.
They usually resemble the parent disk on MR, with T1 hypo intense and T2 iso- / hypo intense. There may be surrounding T2 hyper intensity and a rim of enhancement from inflammatory changes.
This is a crucial diagnosis to make, as a sequestered disk is a contraindication to limited disk procedures (e.g. Percutaneous discectomy) and may result in failed back surgery.

Myxopapillary ependymoma

Findings

Figure 1: Sagittal T1-weighted images reveals an isointense lobulated intradural mass at the level of the conus medullaris.
Figure 2: Sagittal T2-weighted images shows a hyperintense lobulated intradural mass extending from T11 through L2 with numerous small flow voids.
Figure 3: Sagittal T1 post-contrast images demonstrates intense enhancement of the intradural mass centered around the conus.


Diagnosis: Myxopapillary ependymoma


Myxopapillary ependymoma is a slow-growing tumor arising from the ependymal cells of the filum terminale. These tumors compromise 13% of all spinal ependymomas, and they occur almost exclusively in the conus, filum terminale, and cauda equina although extradural occurence in the sacrum and presacral region has also been reported.

The lesions tend to span two to four vertebral segments, and appear as a well-circumscribed intradural masses. In most cases the tumor is intrinsic to the conus medullaris but this is often difficult to recognize on imaging as the bulk of the mass is extramedullary. Typical MR characteristics include T1 isointensity, T2 hyperintensity, and avid enhancement on post-contrast images. As these tumors are prone to hemorrhage, a hypointensity at the tumor margin is often seen indicative of hemosiderin. Calcification and cyst formation within the mass are not infrequent.

On radiography and CT, vertebral changes can be seen which include widened interpediculate distance, thinned pedicles, posterior vertebral scalloping, and intervertebral foraminal widening due to tumor extension.

They are more common in males (M:F=2:1) with a mean age of 35 at diagnosis. Clinically, they present with back pain, paraparesis, radiculopathy, and occasionally bowel and bladder dysfunction. Because these symptoms can mimic those of disc herniation, there is often a delay in diagnosis. Treatment consists of surgical resection, and the prognosis is excellent with complete resection. Leptomeningeal seeding metastasis in myxopapillary variety is not as frequent as it is in classic spinal cord ependymomas and associated with poorer prognosis when present. Radiotheraphy after surgery improves outcome.

Capillary Telangiectasia

Findings

There is an ill-defined enhancing focus in the medial right temporal lobe on post gadolinium contrast T1-weighted imaging (Figure 4). There is no corresponding signal abnormality or mass on the precontrast T1-weighted, T2-weighted, or FLAIR images (Figure 1, Figure 2, and Figure 3, respectively). There is no mass effect. On susceptibility-weighted imaging (SWI) the lesion shows hypointensity (Figure 5).


Diagnosis: Capillary Telangiectasia


Brain capillary telangiectasias are benign vascular malformations which are often found incidentally.
They can be visualized by gadolinium contrast and gradient-echo susceptibility or susceptibility weighted imaging, but not through catheter angiography, and may often not be visible on conventional T1/T2, FLAIR, or diffusion-weighted imaging.
Often asymptomatic and usually no treatment is required.

Brain capillary telangiectasias (BCTs) are one of four major types of vascular malformations which occur in the brain (the other three are arteriovenous malformations, cavernous malformations (cavernous angiomas), and developmental venous anomalies (venous angiomas), and represent up to 20% of all intracranial vascular lesions. BCTs consist of multiple ectatic capillaries surrounded by normal brain parenchyma and are usually devoid of calcification, gliosis, extraluminal hemorrhage, and hemosiderin-laden macrophages. BCTs are most common in the midbrain, pons, medulla, and spinal cord, but they are found throughout the central nervous system. Multiple BCTs are possible, especially in certain syndromes (e.g.; ataxia telangiectasia, Osler-Weber-Rendu, or Sturge-Weber syndrome).

Often found incidentally, BCTs are usually benign, small in size, and rarely grow over time. They are rarely symptomatic and are not associated with any particular clinical feature but have been reported to be associated with headache, vertigo, and tinnitus.

BCTs are relatively well visualized through susceptibility weighted imaging where they demonstrate marked signal intensity loss due to deoxyhemoglobin present in slow flowing blood. They are also well visualized through gadolinium-enhanced T1-weighted imaging sequences where they are seen as small faint lesions. BCTs are difficult to visualize through conventional T1/T2, FLAIR, or diffusion-weighted imaging and are considered to be one of the “angiographically occult vascular malformations” due to their small size, tendency to occlude, and sluggish flow.

Wernicke’s Encephalopathy

Findings

On axial images, abnormal FLAIR signal is demonstrated at the pontomedullary junction adjoining the fourth ventricle, periaqueductal gray matter in the pons and midbrain (Figure 1), the superior aspect of the mamillary bodies (Figure 2), the tissue surrounding the third ventricle and the medial thalami (Figure 3).
On coronal slices, abnormal FLAIR signal again appears in the mamillary bodies (Figure 8), in the tissue surrounding the third ventricle (Figure 8 and Figure 10), medial thalami (Figure 10), and periaqueductal gray matter (Figure 11).


Diagnosis: Wernicke’s Encephalopathy


Wernicke’s encephalopathy is caused by thiamine deficiency, most often seen in chronic alcohol abuse. It has also been described in anorexia nervosa, prolonged starvation, hyperemesis gravidarum, patients on long-term hemodialysis, and patients with AIDS. Patients with this condition classically present with the triad of ataxia, acute mental confusion, and oculomotor dysfunction, although a minority (16-38%) of patients with the condition present with all three elements. If the symptoms also include amnesia and confabulation, then these manifestations are called Korsakoff syndrome. Wernicke’s encephalopathy is a significantly disabling and potentially lethal condition that can be prevented and reversed if treated early with thiamine supplementation.

On CT and MR imaging the brain demonstrates diffuse cerebral and cerebellar atrophy. Mamillary body enhancement or abnormal T2 signal may be the sole manifestation of Wernicke’s encephalopathy. Other typical MR findings include symmetric high T2 signal and variable enhancement within the periaqueductal gray matter of the midbrain, the tectal plate, the mamillothalamic tract, the thalami, and the tissue surrounding the third ventricle. The mamillary bodies may also show atrophy in patients with chronic Wernicke’s encephalopathy, though this finding can also be present in chronic alcoholic patients without Wernicke’s syndrome. Atypical changes may also be seen, almost always in non-alcoholic patients, and may include signal changes in cranial nerve nuclei, basal ganglia, cerebellum and dentate nuclei, the splenium, and frontal and parietal cortex. These atypical findings are very similar to the pattern seen in metronidazole-induced encephalopathy, and it is has been hypothesized that the two syndromes share a common metabolic pathway. The reason why these brain regions are more affected by thiamine deficiency is poorly understood, but it is speculated that they may be characterized by more intense thiamine metabolism.

Methotrexate neurotoxicity

Additional clinical history: Patient was diagnosed with acute lymphocytic leukemia 2 months previously. He is status post induction therapy with a negative bone marrow biopsy, and is currently receiving consolidation chemotherapy with methotrexate, and presents with right upper extremity weakness.


Findings

MR images of the brain demonstrate a focal area of diffusion restriction involving the left frontoparietal white matter. There is minimal associated T2/FLAIR hyperintensity. No associated enhancement. Remainder of the brain was within normal limits.
Imaging done four months later shows lesion has nearly resolved.


Diagnosis: Methotrexate neurotoxicity


Discussion

Methotrexate is a folic acid analogue. Its cytotoxic effects are carried out through inhibition of the enzyme dihydrofolate reductase, which reduces tetrahydrofolic acid levels, ultimately inhibiting cell division.

From bone marrow cell precursors to the quickly dividing cells of the intestinal tract, methotrexate exerts its effects on all dividing cells in the body. One of its rare side effects is CNS toxicity. The decreased folate levels achieved with methotrexate have implications on metabolism of adenosine, homocysteine, and biopterin. Low folate levels lead to a subsequent decrease in S-adenosyl-methionine(SAM) concentrations. This eventually leads to chronic demyelination and neurologic symptoms.

An additional side effect of MTX is the elevated levels of adenosine in the CSF. Adenosine is a vasodilator, which causes dilatation of cerebral vasculature resulting in neurotoxicity. The increased homocysteine levels caused by MTX have been shown to damage vascular endothelium and lead to subsequent strokes and thromboemboli. Methotrexate has also been found to cause cytotoxic edema, which is the most common cause of lesions that enhance on MRI DWI.

The neurotoxicity caused by MTX can be immediate, acute to subacute, or delayed. Symptoms of the disease can range from headache, nausea, vomiting, and fever, to transient or permanent focal neurologic symptoms. The immediate form occurs within a day of MTX administration and presents as a chemical meningitis. The acute to subacute form presents from days to weeks after administration of MTX, and presents with seizures or focal neurologic symptoms. The delayed form presents as leukoencephalopathy and a generalized decrease in higher cognitive function.


Radiological findings

A case series containing nine cases of MTX neurotoxicity revealed that lesions found in this disease tend to be focal and show up on DWI as well as T2 and FLAIR imaging. These abnormalities can continue to persist on imaging long after the symptoms have resolved. The DWI shows diffusion restriction with T2/FLAIR hyperintensity being less conspicuous.

In another independent case study on MTX neurotoxicity, MRI demonstrated restriction diffusion with no significant T2 or FLAIR signal abnormality. Based on a combination of these imaging findings, it was determined that cytotoxic edema was likely the cause of focal neurologic symptoms on the patient, and demyelination was a less likely cause based on the MRI findings.

A different case study had MRI findings showing subtle signal changes in the left centrum semiovale, with an obviously abnormal area of restricted diffusion, indicating the presence of increased fluid. The authors of this case also mentioned a relation between elevated choline levels in lesion areas with myelin breakdown.

The lesion in this disease is similar in appearance to ischemic stroke, but differs in distribution. The lesions in MTX neurotoxicity can show up in many different patterns, whereas ischemic strokes often follow a vascular distribution, helping differentiate the two.


Radiology

MRI:
MRI with DWI is the gold standard for diagnosis
Will show focal areas of demyelination and/or edema throughout the brain
Can be normal, even in the presence of symptoms
Must perform early to avoid unnecessary workup


CT:
Can be used to rule out other etiologies that may cause focal symptoms, but is not a sensitive test for demyelination and edema found with MTX neurotoxicity
Ultimately need MRI to make diagnosis as CT is often negative
Angiography
Not very useful as it is usually normal

Basilar invagination secondary to rheumatoid arthritis

Findings

Axial and sagittal CT images demonstrate severe basilar invagination (Figure 1). The tip of the odontoid process measures 2.3 cm above Chamberlain’s line (yellow line in Figure 2). McGregor's line (red line in Figure 2) is also shown. Incidentally noted are right-sided opacified mastoid air cells (Figure 1).
Once again, severe basilar invagination is evident. On the sagittal T2 image the foramen magnum is narrowed and obliteration of the CSF space is noted at the C2-C3 level (Figure 3). On the axial T2 weighted image increased T2 signal (Figure 4) is seen within the cord at the C2-C3 level indicating edema versus myelomalacia.



Diagnosis: Basilar invagination (impression) secondary to rheumatoid arthritis.


Basilar invagination refers to a condition in which the odontoid process protrudes upward into the intracranial space. Basilar invagination may be classified as primary (congenital) or secondary (acquired). Down syndrome, Klippel-Feil syndrome and Chiari malformations are congenital causes of basilar invagination. Acquired basilar invagination, also known as basilar impression, is associated with softening of the skull base and is often due to rheumatoid arthritis, Paget disease, osteomalacia, hyperparathyroidism and osteogenesis imperfecta. Basilar invagination is probably better described as a radiologic finding rather than a diagnosis. Once the finding is identified, a cause of basilar invagination should be diligently pursued.

Plain lateral radiographs with odontoid views, although not 100% sensitive, are often the initial study used to diagnose basilar invagination. MRI is the optimal study, which also assesses the cervicomedullary junction and cervical cord. Two craniovertebral junction lines are particularly useful in defining basilar invagination. Chamberlain’s line extends between the posterior pole of the hard palate and the posterior edge of the foramen magnum (opisthion). If the dens is >3.0 mm above this line basilar invagination is present. McGregor’s line, a modification of Chamberlain’s line was developed because the opisthion could not always be seen on plain radiographs. This line extends from the posterior pole of the hard palate to the undersurface of the occiput. If the dens extends >4.5 mm above this line basilar invagination is present.

Clinical manifestations of basilar invagination include posterior skull pain, headache, signs and symptoms of brainstem and upper cervical cord compression or disturbances of CSF circulation causing obstructive hydrocephalus. The brainstem may be compressed at the level of the foramen magnum possibly resulting in compromise of the autonomic centers resulting in labile blood pressures, arrhythmias, or sudden death. Neurosurgery is recommended in patients that are symptomatic with concomitant MRI findings indicating compression. Although asymptomatic patients are often followed conservatively, many authors favor surgery even if no symptoms of cord compression are evident in rheumatoid patients.

Although often appearing together, basilar invagination or impression should not be confused with platybasia; which literally means “flattening of the base of the skull”. Platybasia, which can be seen in Klippel-Feil anomalies, cleidocranial dysplasia and achondroplasia, is present when the basal angle formed by intersecting lines from the nasion to the tuberculum sellae and from the tuberculum along the clivus to the anterior aspect of the foramen magnum (basion) is greater than 143 degrees.